Sofosbuvir for Previously Untreated Chronic Hepatitis C Infection | Zendy

Eric Lawitz | Zendy; Alessandra Mangia | Zendy; David Wyles | Zendy; M. RodríguezTorres | Zendy; Tarek Hassanein | Zendy; Stuart C. Gordon | Zendy; Michael Schultz | Zendy; Mitchell Davis | Zendy; Zeid Kayali | Zendy; K. Rajender Reddy | Zendy; Ira M. Jacobson | Zendy; Kris V. Kowdley | Zendy; Lisa M. Nyberg | Zendy; G. Mani Subramanian | Zendy; Robert H. Hyland | Zendy; Sarah Arterburn | Zendy; Deyuan Jiang | Zendy; John McNally | Zendy; Diana M. Brainard | Zendy; William T. Symonds | Zendy; John G. McHutchison | Zendy; Aasim Sheikh | Zendy; Zobair M. Younossi | Zendy; Edward Gane | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Sofosbuvir for Previously Untreated Chronic Hepatitis C Infection

Author(s) -

Eric Lawitz,

Alessandra Mangia,

David Wyles,

M. RodríguezTorres,

Tarek Hassanein,

Stuart C. Gordon,

Michael Schultz,

Mitchell Davis,

Zeid Kayali,

K. Rajender Reddy,

Ira M. Jacobson,

Kris V. Kowdley,

Lisa M. Nyberg,

G. Mani Subramanian,

Robert H. Hyland,

Sarah Arterburn,

Deyuan Jiang,

John McNally,

Diana M. Brainard,

William T. Symonds,

John G. McHutchison,

Aasim Sheikh,

Zobair M. Younossi,

Edward Gane

Publication year - 2013

Publication title -

new england journal of medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 19.889

H-Index - 1030

eISSN - 1533-4406

pISSN - 0028-4793

DOI - 10.1056/nejmoa1214853

Subject(s) - medicine , sofosbuvir , chronic hepatitis , virology , hepatitis c , ribavirin , virus

In phase 2 trials, the nucleotide polymerase inhibitor sofosbuvir was effective in previously untreated patients with chronic hepatitis C virus (HCV) genotype 1, 2, or 3 infection.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom

About

About Careers Publisher Partners Contact Us Get Organisational Trial or Quote

Learn

FAQs Blog Terms of Use Privacy Policy

Download the Zendy App

Address

About

Learn

Download the Zendy App

Discover

Explore